Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dissemination Of CER Evidence Remains Key Challenge, PCORI Survey Suggests

This article was originally published in The Pink Sheet Daily

Executive Summary

Getting clinicians to access, let alone adopt, clinical comparative effectiveness research findings continues to loom as a key challenge, results from a recent PCORI survey suggest.

Advertisement

Related Content

Making CER Findings Relevant Requires Putting Results In Context – PCORI Board
PCORI Shifts Focus To Dissemination Of Research Findings
Drug Development Needs “Clean-Slate Think” To Involve Patients All Along The Way – Pfizer’s Lewis-Hall
CER Credibility Lies In Methodology For Studies, Physician Tells BIO
PCORI Is A “Transformative Opportunity” – Chairman Washington
CER Has Been A Part Of CMS Coverage Decisions In Recent Years – Avalere

Topics

Advertisement
UsernamePublicRestriction

Register

PS075953

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel